Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) EBIT Margin (2019 - 2025)

Historic EBIT Margin for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to 813.2%.

  • Volitionrx's EBIT Margin rose 4235700.0% to 813.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 1542.24%, marking a year-over-year increase of 7896600.0%. This contributed to the annual value of 2190.9% for FY2024, which is 24508700.0% up from last year.
  • Volitionrx's EBIT Margin amounted to 813.2% in Q3 2025, which was up 4235700.0% from 1548.56% recorded in Q2 2025.
  • In the past 5 years, Volitionrx's EBIT Margin ranged from a high of 813.2% in Q3 2025 and a low of 61692.56% during Q4 2021
  • Over the past 5 years, Volitionrx's median EBIT Margin value was 5237.58% (recorded in 2023), while the average stood at 12211.45%.
  • Per our database at Business Quant, Volitionrx's EBIT Margin skyrocketed by 2000000000bps in 2021 and then skyrocketed by 2176000bps in 2025.
  • Over the past 5 years, Volitionrx's EBIT Margin (Quarter) stood at 61692.56% in 2021, then skyrocketed by 89bps to 6691.45% in 2022, then soared by 46bps to 3582.6% in 2023, then grew by 16bps to 3016.5% in 2024, then surged by 73bps to 813.2% in 2025.
  • Its EBIT Margin stands at 813.2% for Q3 2025, versus 1548.56% for Q2 2025 and 2241.09% for Q1 2025.